Pharmacist‐Led Hepatitis C Diagnosis and Rapid Management—In Community ( PHARM ‐C): Results From a Phase IV Nonblinded Randomised Controlled Trial

This was a nonblinded randomised controlled trial comparing pharmacist‐led hepatitis C virus (HCV) treatment in the community, to tertiary care hepatology. Of 34 antibody‐positive individuals, 28 completed a rapid HCV RNA test in the pharmacy. The study was terminated after randomising 11 participants over 15 months (recruitment continued until ~27 months), as a result of feasibility concerns of pharmacist‐led care, and here we highlight important lessons learned to consider for future efforts.